Detection of Activated Pepsin in Bronchoalveolar Lavage and Acute Cellular Rejection in Lung Transplant Recipients
Abstract
(ISSN 2577-5820)
OBM Transplantation (ISSN 2577-5820) is an international peer-reviewed Open Access journal published quarterly online by LIDSEN Publishing Inc., which covers all evidence-based scientific studies related to transplantation, including: transplantation procedures and the maintenance of transplanted tissues or organs; assimilation of grafted tissue and the reconstitution of removed organs or parts of organs; transplantation of heart, lung, kidney, liver, pancreatic islets and bone marrow, etc. Areas related to clinical and experimental transplantation are also of interest.
OBM Transplantation is committed to rapid review and publication, and we aim at serving the international transplant community with high accessibility as well as relevant and high quality content.
We welcome original clinical studies as well as basic science, reviews, short reports/rapid communications, case reports, opinions, technical notes, book reviews as well as letters to the editor.
Publication Speed (median values for papers published in 2023): Submission to First Decision: 6.7 weeks; Submission to Acceptance: 14.4 weeks; Acceptance to Publication: 6 days (1-2 days of FREE language polishing included)
Detection of Activated Pepsin in Bronchoalveolar Lavage and Acute Cellular Rejection in Lung Transplant RecipientsAbstract Activated pepsin (pepA) in bronchoalveolar lavage (BAL) fluid may be a biomarker of gastric aspiration. We sought to i) evaluate the association of pepA in BAL fluid with acute cellular rejection (ACR) in a cohort of lung transplant recipients (LTRs), ii) assess the association between pepA and isolation of typical gastrointestinal microorganisms from [...] |
Management of Calcareous Corneal Degeneration from Medication Washout to Corneal Transplantation. Case Series and Review of the LiteratureAbstract Calcareous corneal degeneration is a rare disease characterized by calcium phosphate deposition into the deep corneal layers. Corneal calcification has a multifactorial origin and is associated with various systemic and ocular conditions. Several treatment options showed promising results in the management of this disorder. Herein, two cases of calcareo [...] |
Circulating lncRNAs HOTTIP and HOTAIR as Potential Biomarkers in Crigler-Najjar Syndrome: A Preliminary Report from Shiraz Liver Transplant Research Centerby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Crigler-Najjar syndrome (CNS) is a rare autosomal recessive disorder characterized by impaired bilirubin metabolism, leading to neurotoxic unconjugated bilirubin accumulation. Liver transplantation remains the only effective treatment, highlighting the need for novel diagnostic and therapeutic approaches. Long non-coding RNAs (lncRNAs) have emerged [...] |
Is Donation after Circulatory Determination of Death in Japan Uncontrolled or Controlled?Abstract Using donation after circulatory determination of death (DCD) donors has been shown to be a potential means of increasing the number of donors for organ transplantation. The purpose of this study was to examine the published practice of DCD in Japan to properly define their practice as controlled or uncontrolled. Through the Web of Science database [...] |
Advances in Managing Infections in Lung Transplantation: A Reviewby
![]() ![]() Abstract Transplanted lung allografts are particularly susceptible to infection among SOT due to the constant exposure to the environment, aggressive immunosuppressive strategies, and impaired clearance mechanisms after denervation of the transplanted lung. Though prophylactic antimicrobial, antifungal, and antiviral regimens are used as preventive strategies [...] |
Frequency of Unplanned Readmissions Following Lung Transplantation During the SAR-COV-2 Pandemic When Hospital Resources Were Strainedby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Despite the concerted efforts by lung transplant recipients (LTR) and their medical teams, hospital readmissions are common in the first year following transplantation. Reasons for unplanned readmissions include allograft rejection, infections, and respiratory failure before the SARS-COV-2 pandemic. Clinical predictors of readmissions have changed over [...] |
Low Mortality Associated with COVID-19 Infection in Lung Transplant Recipients at a Single Centerby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Lung Transplant Recipients (LTR) are particularly vulnerable to severe infection, hospitalization, and death due to community acquired respiratory viruses. As a result, the global SARS-Cov-2 pandemic poses a higher risk to this population. We aim to study the lung function, severity of infection and mortality among LTR at a single center. A retrospectiv [...] |
Contribution of a Single Islet Transplant Program to Basic Researchers in North America, Europe, and Asia through Distributing Human Isletsby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract There has been a steady expansion in islet isolation and transplantation activity worldwide. In addition to preparing human islets for transplantation, we have been providing human islets to basic researchers. The aim of this study was to review the activity of distribution of human islets to basic researchers in North America, Europe, and Asia, and [...] |
Thrombotic Microangiopathy in Solid Organ Transplantationby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Thrombotic Microangiopathy (TMA) is a syndrome characterized by microangiopathic hemolytic anemia (MAHA) and thrombocytopenia. The presence of schistocytes on peripheral smear, a negative Coombs test, elevated lactate dehydrogenase, increased reticulocyte count and low haptoglobin are often the clues for MAHA. The microvascular process often targets [...] |
Management of Steatosis in Living Donors: Where Do We Stand?Abstract With the progressive rise in rates of liver transplantation, stagnant donor pool, and social factors, living donor liver transplantation (LDLT) forms the majority of liver transplantations performed in Asian countries. As the global prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing, around 17-25% of all the prospective donors [...] |
Airway Complications after Lung Transplantationby
![]() ![]() Abstract Lung transplantation in patients with end stage lung disease can improve survival and quality of life. Airway complication incidence varies between 2-33%, but the true incidence is difficult to determine due to a lack of validated classification systems. There are many risk factors for post lung transplant airway complications, the most common being [...] |
Calculated Human Leucocyte Antigens Evolutionary Divergence (cHED)by
![]() Abstract Human Leucocyte Antigens (HLA) constitute a highly polymorphic set of genes pivotal to the immune response. The HLA heterozygous advantage hypothesis assumes that heterozygous individuals at the HLA level have a wider range of peptides for T cell recognition than homozygous individuals. Consequently, they possess an enhanced capacity to trigger a target [...] |
Chronic Lung Allograft Dysfunction, a Review in 2023Abstract Chronic allograft dysfunction (CLAD) is one of the leading causes of death after lung transplantation [1]. CLAD is a progressive and irreversible decline in lung function after transplant, manifested as an obstructive, restrictive, or mixed ventilatory impairment without any identifiable etiology as infection or acute rejection. Multiple risk factors [...] |
Evaluation of Total Parenteral Nutrition in the Autologous Transplantation Setting in Patients with AML: A Retrospective Exploratory Analysisby
![]() ![]() ![]() ![]() ![]() ![]() Abstract Malnutrition remains a clinical challenge in AML patients undergoing autologous hematopoietic stem cell transplantation (ASCT), leading to physical deconditioning and prolonged hospitalization. Prospective data are mainly lacking to identify those patients who may particularly benefit from parenteral nutrition in this setting. This observational, non [...] |
Acknowledgement to Reviewers of OBM Transplantation in 2023Abstract The editors of OBM Transplantation would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2023. We greatly appreciate the contribution of expert reviewers, which is crucial to the journal’s editorial process. We aim to recognize reviewer contributions through several mechanisms, of which the annual public [...] |
Immune-Suppression Modulation in Solid Organ Transplant Recipients Admitted for COVID-19by
![]() ![]() ![]() ![]() ![]() ![]() Abstract SARS-CoV-2 infection has significantly impacted solid organ transplant (SOT) recipients, who are at high risk of disease and worse outcomes. Moreover, therapeutic management in this population is not precise yet. Our study aimed to evaluate the overall survival of SOT recipients and predictive factors for mortality. We also aimed to assess the impact [...] |
Lung Donor Selection and Management: An Updated Reviewby
![]() ![]() ![]() ![]() ![]() ![]() Abstract The shortage of donor lungs for transplantation is a major challenge, resulting in longer waitlist times for patients with a higher risk of waitlist mortality. It is crucial to continue promoting awareness about organ donation through legislation, public campaigns, and health care provider education. Only a small number of cadaveric donors meet the [...] |
Acute Rejection of the Lung Allograft: Phenotypes and ManagementAbstract Treatment options for end stage lung diseases are limited to stabilizing lung failure, decreasing disease progression, and symptom management, but significant reversal of lost lung function is often not possible. For well selected patients, lung transplantation may be a viable option to improve both longevity and quality of life. Though outcomes for [...] |
HLA Typing and Donor-Specific Antibody Screening in Kidney Transplantation: Bridging the Past to the Futureby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Human leukocyte antigens (HLA) are unique proteins expressed on the surface of human cells, playing a pivotal role in the immune system, particularly in the contexts of infection, cancer, and transplantation. The widespread adoption of HLA typing methods has become an essential component in assessing donor-recipient compatibility, a crucial limiting [...] |
Peri-transplant Treatment with Ceftaroline in Kidney Transplant Recipients at Risk of Donor-derived MRSA Infections: A Case Seriesby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract The rising prevalence of MDR pathogens has a significant impact on the recipients' outcome, as this increases the risk of graft complications and makes the management of the peri-transplant phase more difficult. Among the different MDR germs, Methicillin-resistant Staphylococcus aureus (MRSA) represents one of the most frequently isolated pathogens [...] |
Utility of MEST and MEST-C Scoring in IgA Nephropathy in Kidney Transplantation: A Mini ReviewAbstract IgAN is a major cause of end-stage kidney disease (ESKD) leading to kidney transplantation in a significant proportion of patients. However, its recurrence in transplanted kidneys can lead to graft loss. The rate of graft loss attributable to IgAN after transplantation is variably reported in different retrospective cohorts. Previous reports describe [...] |
Multimodal Pain Management of Liver Transplantation: What Is New?Abstract Liver transplantation (LT) is a life-saving treatment representing the only viable option for patients suffering from end-stage liver disease (ESLD) or acute liver failure. Patients who undergo LT require a multidisciplinary approach to postoperative pain management. However, pain management in this context is often inadequately explored. Limited option [...] |
Lung Transplantation: Selection of CandidatesAbstract Lung transplantation is a last-resort treatment option for patients with end stage lung disease. The procedure is being performed more frequently and scientific advances continue to be made, but the median post-transplant survival is far shorter than other solid organ transplant recipients. Candidate selection is a resource intensive process that attemp [...] |
A Urinary Proteomics Approach to Predict Treatment Response in Acute Antibody-Mediated Rejectionby
![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Acute antibody-mediated rejection (AMR) is a severe complication affecting kidney allografts' long-term survival. Timely detection and appropriate treatment of AMR are crucial for improving graft outcomes. This study aimed to discover non-invasive urinary biomarkers that can predict the response to therapy in patients with AMR. Materials and Methods: [...] |
Oral Versus Intravenous Anti-CMV Preemptive Strategies in Allogeneic Stem Cell Transplant Patients with CMV Reactivation: Experience from the National Center of Bone Marrow Transplantation, Tunis, Tunisiaby
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Abstract Cytomegalovirus (CMV) infection is a common and severe complication following allogeneic stem cell transplantation (ASCT) and requires effective preemptive antiviral therapy. Both oral and intravenous (IV) antiviral agents effectively reduce CMV viral load and achieve viral clearance. Studies comparing oral and IV anti-CMV preemptive treatment in ASCT [...] |
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Eric M. Bluman from Brigham and Women's Hospital, USA, to join the Editorial Board of OBM Transplantation. Dr. Bluman is an Associate Professor in the Department of Orthopedic Surgery at Harvard Medical School. He has extensive experience in orthopaedic surgery, complex reconstruction of foot and ankle deformity, cartilage transplantation, allograft ligament reconstruction, and bone grafting. We are grateful to Dr. Bluman for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Miriana d'Alessandro from University of Siena, Italy, to join the Editorial Board of OBM Transplantation. Dr. d'Alessandro is a renowned scholar who has extensive experience in pulmonary fibrosis, interstitial lung disease, bronchoalveolar lavage, immunology, respiratory diseases, flow cytometry, extracellular vesicles. We are grateful to Dr. d'Alessandro for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Sotiria Palioura from Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Palioura is a renowned scholar who has extensive experience in cornea transplantation, cataract surgery, refractive surgery, management of ocular surface tumors and inflammatory diseases. We are grateful to Dr. Palioura for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Gaetano Isola from University of Catania, Italy, to join the Editorial Board of OBM Transplantation. Dr. Isola is an Associate Professor of Periodontology at the University of Catania. He has extensive experience in periodontal disease, oral medicine, oral biology. We are grateful to Prof. Isola for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Jeffrey J. Pu from the Harvard Medical School, USA, to join the Editorial Board of OBM Transplantation. Dr. Pu is an Associate Professor of Medicine. He has extensive experience in hematopoietic mechanism of hematological malignant disease progression, stem cell biology, biomarker translational research, cellular therapy, early phase clinical trials, and HCTT outcome-research. We are grateful to Dr. Pu for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Clotilde Castaldo from University of Naples Federico II, Italy, to join the Editorial Board of OBM Transplantation. Dr. Castaldo is a Full Professor of the Department of Public Health at University of Naples Federico II. She has extensive experience in adult stem cells, iPSCs, 3D cell culture, decellularization, cardiac tissue engineering, and regenerative medicine. We are grateful to Dr. Castaldo for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Luca Testarelli from Sapienza University of Rome, Italy, to join the Editorial Board of OBM Transplantation. Dr. Testarelli is an Associate Professor of the Department of Oral and Maxillofacial Sciences at the Sapienza University of Rome. He has extensive experience in endodontics, oral surgery, 3D in dentistry, implantology, dental materials. We are grateful to Dr. Testarelli for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Christopher Bibbo from Sinai Hospital of Baltimore, USA, to join the Editorial Board of OBM Transplantation. Dr. Bibbo is the Head of Foot and Ankle Surgery and the Assistant Director of the Foot and Ankle Deformity Correction and Orthoplastics Fellowship at the International Center for Limb Lengthening. He has extensive experience in foot and ankle treatment, foot and ankle sports medicine, plastic reconstructive & microsurgery, peripheral nerve reconstruction, orthopedic trauma and musculoskeletal infections. We are grateful to Dr. Bibbo for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. James F. Thornton from University of Texas Southwestern Medical Center, USA, to join the Editorial Board of OBM Transplantation. Prof. Thornton is a Professor in the Department of Plastic Surgery at the University of Texas Southwestern Medical Center at Dallas, and is the holder of the Ellen Hecht Chair in tissue transplantation. He has extensive experience in skin, plastic surgery, Mohs reconstruction, reconstructive breast surgery, head and neck reconstruction, upper and lower extremity reconstruction, abdominal wall reconstruction. We are grateful to Prof. Thornton for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Antonino Maniaci from Kore University of Enna, Italy, to join the Editorial Board of OBM Transplantation. Dr. Maniaci is a renowned scholar who has extensive experience in rhinology, OSAS, laryngology, otolaryngology, salivary gland, head and neck, ENT surgery. We are grateful to Dr. Maniaci for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Anastasiia V. Bondarenko from International European University, Ukraine, to join the Editorial Board of OBM Transplantation. Prof. Bondarenko is the Head of the Department of Pediatrics, Immunology, Infectious and Rare Diseases at International European University. She has extensive experience in primary immunodeficiencies, infectious diseases, immunology of infectious diseases, vaccines, immunoprophylaxis. We are grateful to Prof. Bondarenko for her participation and support.
It is our pleasure to announce that LIDSEN has joined the ORCID community. ORCID (Open Researcher and Contributor ID), a global, not-for-profit organization, provides a free, unique, and persistent digital identifier (an ORCID iD), which can automatically link researchers to their own contributions, so as to disambiguate researchers from one another. Authors who publish with OBM Transplantation are greatly encouraged to register for a unique iD to ensure proper attribution.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Maurizio Salvadori from Careggi University Hospital, Italy, to join the Editorial Board of OBM Transplantation. Prof. Salvadori is a Professor, Professor, Department of Renal Transplantation, Careggi University Hospital, viale Pieraccini 18, 50139 Florence, Italy. Prof. Salvadori has extensive experience in kidney transplantation, transplantation, clinical nephrology, chronic renal failure, immunology, infectious diseases, and antibody-mediated rejection. We are grateful to Prof. Salvadori for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Tatsuya Kin from University of Alberta, Canada, to join the Editorial Board of OBM Transplantation. Dr. Kin is the Director, Clinical Islet Laboratory, Department of Surgery, University of Alberta, 112 Street & 87 Avenue, Edmonton, AB T6G 2E1, Canada. Dr. Kin has extensive experience in islet isolation, islet transplantation, organ preservation, organ donation, transplantation, and diabetes. We are grateful to Dr. Kin for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Luca Brazzi from University of Turin, Italy, to join the Editorial Board of OBM Transplantation. Prof. Brazzi is a Professor, Chief, Director, Department of Surgical Science, University of Turin, University Hospital Città della Salute e della Scienza, Corso Dogliotti 14, 10126 Turin, Italy. Prof. Brazzi has extensive experience in anaesthesiology, transplant anaesthesiology, anaesthetics, and preservation of donor organs. We are grateful to Prof. Brazzi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Nidhi Sharma from Ohio State University, USA, to join the Editorial Board of OBM Transplantation. Dr. Sharma is from Division of Hematology, Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH, USA. Dr. Sharma’s research interest is in the field of stem cell transplantation (autologous and allogenic), and graft vs host disease (GVHD). We are grateful to Dr. Sharma for the participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Marina Moguilevitch from Montefiore Medical Center, Albert Einstein College of Medicine, USA, to join the Editorial Board of OBM Transplantation. Prof. Moguilevitch is an Associate Professor of Clinical Anesthesiology, Director of Transplant Anesthesia Service, Divsion of Transplant Anesthesiolgy, Department of Anesthesiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY, USA. She has extensive experience in anesthesiology, transplant anesthesiology, and liver transplantation. We are grateful to Prof. Moguilevitch for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Prof. Malcolm Voyce from Macquarie Law School, Macquarie University, Australia, to join the Editorial Board of OBM Transplantation. Prof. Voyce is a Professor of Law, Macquarie Law School, Macquarie University, NSW 2109 Australia. He has extensive experience in property law and succession concerning the privatisation of public property, geographical indications, intellectual property rights, social welfare, family farm inheritance and organ transplants, law and religion, and Buddhism and Islam. We are grateful to Prof. Voyce for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Maricar Malinis from Yale School of Medicine, USA, to join the Editorial Board of OBM Transplantation. Dr. Malinis is an Associate Professor of Medicine and Surgery (Transplant), Medical Director, Transplant Infectious Diseases, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. She has extensive experience in aging, CMV, fungal infections, immunocompromised host and transplant infectious diseases. We are grateful to Dr. Malinis for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Paolo Muiesan from Queen Elizabeth & Birmingham Children's Hospitals, USA, to join the Editorial Board of OBM Transplantation. Professor Muiesan is the Professor of HPB Surgery & Liver Transplantation, Liver Unit, Queen Elizabeth & Birmingham Children's Hospitals, Mindelsonway, Birmingham B15 2TH, United Kingdom. He has extensive experience in adult and paediatric liver transplantation, hepatobiliary surgery, liver tumors, general surgery, vascular surgery, laparoscopic liver surgery, liver resections for cholangiocarcinoma, parenchymal sparing central resections, ALPPS and ex-vivo resections. We are grateful to Prof. Muiesan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mohammed Moghadasian from University of Manitoba, Canada, to join the Editorial Board of OBM Transplantation. Professor Moghadasian is the Professor of Nutrition, Department of Food and Human Nutritional Sciences, University of Manitoba, Winnipeg, Manitoba, Canada. He has extensive experience in diet, lipoprotein metabolism, coronary artery disease, diet-drug interaction, and diets and transplantation. We are grateful to Prof. Moghadasian for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Esma S. Yolcu to join the Editorial Board of OBM Transplantation. Dr. Yolcu is an Associate Professor at Department of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville School of Medicine, Louisville, USA. Her main research interests are immunotherapy, ProtEx™ technology, gene therapy, immunomodulation, tolerance, host-versus-graft (HVG) and graft-versus-host (GVH). We are grateful to Dr. Yolcu for her participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We sincerely welcome Professor Haval Shirwan from University of Louisville, USA, to lead the journal OBM Transplantation as the Editor-in-Chief. Professor Shirwan is an internationally renowned immunologist recognized for his pioneering approach to generate novel immunological ligands and their transient and positional display on biologic and nonbiologic surfaces for localized immunomodulation with applications to transplantation, autoimmunity, and cancer immunoprevention and immunotherapy. We appreciate Professor Haval Shirwan for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Mureo Kasahara from National Center for Child Health and Development, Tokyo, Japan, to join the Editorial Board of OBM Transplantation. Prof. Kasahara is the Director, Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan. He has extensive clinical experience in the kidney transplantation, liver transplantation, liver surgery, pediatric organ transplantation, liver diseases and immunology, transplant immunology, transplant medicine and transplant surgery. We are grateful to Prof. Kasahara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Associate Professor Chirag S. Desai to join the Editorial Board of OBM Transplantation. Dr. Desai is an Associate Professor at Department of Surgery, University of North Carolina, Chapel Hill, NC, USA. His main research interests are liver transplantation, intestinal and multivisceral transplantation, liver and pancreatobiliary disorders, chronic pancreatitis and autologous islet cell transplantation. We are grateful to Dr. Desai for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Sherif Beniameen Mossad to join the Editorial Board of OBM Transplantation. Dr. Mossad is a staff physician in the Department of Infectious Disease, Respiratory Institute, and Transplantation Center, Cleveland Clinic, Ohio, USA. His main research interests are transplant infectious disease, influenza and common cold. We are grateful to Dr. Mossad for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor René Adam to join the Editorial Board of OBM Transplantation. Dr. Adam is a Professor and Head Department of Hepatobiliary Surgery, Cancer and Transplantation, Centre Hepato-Biliaire, Hopital Paul-Brousse, 94804 Villejuif, France. His main research interests are surgery of the liver, biliary tract and pancreas, hepatic transplantation, liver diseases, hepatocellular carcinoma, hepatobiliary surgery, and liver transplantation. We are grateful to Dr. Adam for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Yasuhiko Sugawara to join the Editorial Board of OBM Transplantation. Dr. Sugawara is a Professor at Department of Surgery, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Japan. His main research interests are hepatobiliary surgery and liver transplantation. We are grateful to Dr. Sugawara for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Professor Taizo Hibi to join the Editorial Board of OBM Transplantation. Dr. Hibi is a Professor and Chairman at the Department of Transplantation and Pediatric Surgery, Kumamoto University Graduate School of Medical Sciences, Japan. His main research interests are surgical oncology, hepatobiliary and pancreatic surgery, living donor liver transplantation, intestinal/multivisceral transplantation, and transplant/tumor immunology. We are grateful to Dr. Hibi for his participation and support.
OBM Transplantation Welcomes New Editorial Board Member
We welcome Dr. Kåre I. Birkeland to join the Editorial Board of OBM Transplantation. Dr. Birkeland is a Professor at the Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway. His main research interests are diabetes, clinical and mechanistic studies; insulin resistance and metabolic syndrome; laboratory endocrinology; and islet and pancreas transplantation. We are grateful to Dr. Birkeland for his participation and support.
OBM Transplantation welcomes the following types of articles: original research, review, communication, opinion, case report, comment, conference report, technical note, book review, etc. There is no restriction on the length of the papers, color figures, supplementary file types. More details please see Instructions for Authors.
Original Research
by Tatsuya Kin et al.
OBM Transplantation 2024
Published: 23 April 2024
Review
by Onix Cantres Fonseca et al.
OBM Transplantation 2024
Published: 20 February 2024
Original Research
by Sarah Willi et al.
OBM Transplantation 2024
Published: 04 February 2024
Review
by Sravanthi Nandavaram et al.
OBM Transplantation 2024
Published: 10 April 2024
Original Research
by Rahul Gomez et al.
OBM Transplantation 2024
Published: 28 April 2024
TOP